Congress has extended telehealth flexibilities through its recent federal spending bill, H.R. 1968, titled “Full-Year Continuing Appropriations and Extensions Act, 2025” (the Act). Notably for health care providers, among...more
The Drug Enforcement Administration (DEA), in concert with other federal agencies, has taken various steps in the past few months to strengthen a practitioner’s ability to prescribe controlled substances via telemedicine, a...more
2/25/2025
/ Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Health Care Providers ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Agenda ,
Rulemaking Process ,
Ryan Haight Act ,
Telehealth ,
Telemedicine
We continue our New Jersey Regulatory Update with this Part II, which focuses on regulations that were finalized in the second half of 2024 and impact healthcare. For example, as a continuation of price transparency efforts,...more
The Centers for Medicare & Medicaid Services (CMS), the Office of the National Coordinator for Health Information Technology (ONC), and thr Department of Health and Human Services (HHS) published 89 FR 51238 (the Final Rule),...more
It is that time of year for our regulatory update. Parts I and II will discuss proposed and adopted rules from the second half of last year to the first quarter of this year that impact healthcare providers in New Jersey,...more
5/8/2024
/ Abortion ,
Background Checks ,
Certifications ,
Continuing Education ,
Coronavirus/COVID-19 ,
Disabilities ,
Donations ,
Executive Orders ,
Healthcare ,
License Renewals ,
Long Term Care Facilities ,
Medicaid ,
Mental Health ,
New Jersey ,
Office of Consumer Affairs ,
Physicians ,
Prescription Drugs ,
Regulatory Standards ,
State Health Departments